open-burger-menu
Search Icon
Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research
📈 NEW Report: Abortions, Tax Funding UP at Planned Parenthood >>
Search Icon
Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

close-panel
Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Research Type:

Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research

Sort 1464 results by:

Filter results further
Filter Applied. Clear All

Latest Posts

October 6, 2026 A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review October 6, 2026 Inside The Government Decision That Opened Up Abortion Pill Floodgates Inside The Government Decision That Opened Up Abortion Pill Floodgates October 6, 2026 Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone
Research Type
Publication Type
By State
See All
By Author
See All
Reset All Filters

Did You Know ?

Did You Know ?

In the fourth week, the embryonic heart starts beating. The neural tube, which becomes the brain and spinal cord, forms. At this point, a woman has likely only been aware of her pregnancy for one week.

Did You Know ?

In the seventh week after conception, networks of neurons produce brain waves that have been recorded as early as 6 ½ weeks after conception. The embryo spontaneously moves his arms, hands, and legs, and may even hiccup. The embryo’s heart now has all four chambers.

Did You Know ?

By the seventeenth and eighteenth week after gestation, the fetus shows a clear response to pain in multiple studies, and at least one brain pathway is mature enough to create a perception of pain. The fetus also practices breathing, crying, and breastfeeding in the womb. The fetal heart has beat over 20 million times and circulates about 55 quarts of blood per day.

Did You Know ?

In the eighth month of pregnancy the fetal brain is ready to learn! At 32 weeks after conception, neurons are creating 40,000 new connections, called synapses, every second! With repeated exposures, the fetus can learn flavors, nursery rhymes, songs, and even words that she will recognize after birth!

A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review
Latest Research / Life & the Law

A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review

This paper critically analyzes the FDA's 2021 REMS Review leading to the removal of the in-person dispensing requirement for mifepristone.

Zachary Sluzala,… Ingrid Skop,…
October 6, 2026
Inside The Government Decision That Opened Up Abortion Pill Floodgates
Latest Research / Abortion Drugs

Inside The Government Decision That Opened Up Abortion Pill Floodgates

The decision "fell well short" of the FDA's standards.

charlotte-lozier-institute Charlotte Lozier Institute
October 6, 2026
Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone
Latest Research / Life & the Law

Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone

This paper critically analyzes the FDA's 2021 literature review that served as the basis for its controversial decision to remove…

Ingrid Skop,…
October 6, 2026
Peer-Reviewed Article: FDA Lacked Evidence to Drop In-Person Abortion Drug Requirement
Latest Research / General

Peer-Reviewed Article: FDA Lacked Evidence to Drop In-Person Abortion Drug Requirement

A new peer-reviewed article on the Food and Drug Administration’s (FDA) 2021 complete review of mifepristone’s Risk Evaluation and Mitigation…

charlotte-lozier-institute Charlotte Lozier Institute
October 6, 2026
Abortion Reporting: Kentucky (2025)
Latest Research / Maternal & Public Health

Abortion Reporting: Kentucky (2025)

In 2025, five brick-and-mortar abortions were reported in Kentucky by the state’s Cabinet for Health and Family Services. The data…

Elyse Gaitan Mia Steupert,…
October 5, 2026
Letter from Aaron Kheriaty, M.D., to American Medical Association in Opposition to Physician-Assisted Suicide
End of Life

Letter from Aaron Kheriaty, M.D., to American Medical Association in Opposition to Physician-Assisted Suicide

For almost a quarter of a century, the American Medical Association (AMA) has opposed physician-assisted suicide, stating that it is “fundamentally incompatible with the physician’s role as healer, would be difficult or impossible to control, and would pose serious societal risks.”

charlotte-lozier-institute Charlotte Lozier Institute
February 16, 2017
Written Testimony of George Delgado, M.D., F.A.A.F.P., in Support of Colorado Abortion Pill Reversal Bill
Abortion

Written Testimony of George Delgado, M.D., F.A.A.F.P., in Support of Colorado Abortion Pill Reversal Bill

On Thursday, February 9, 2017, the Colorado House Health, Insurance and Environment Committee held a hearing regarding House Bill 1086 (HB 1086), the Abortion Pill Reversal Information Act. HB 1086 provides that prior to initiating a chemical abortion, a physician must alert the woman to the fact that it may be possible to reverse the abortion should she change her mind and that information on the possibility of reversal is available in state-prepared materials.

George Delgado, M.D.,…
February 16, 2017
Written Testimony of Tara Sander Lee, Ph.D., in Support of Texas Bill to Prohibit Human Fetal Tissue Research
Life & the Law

Written Testimony of Tara Sander Lee, Ph.D., in Support of Texas Bill to Prohibit Human Fetal Tissue Research

On Wednesday, February 15, 2017, the Texas Committee of Health and Human Services held a hearing regarding Texas Senate Bill 8 (SB 8). SB 8 prohibits partial-birth abortions, prohibits donation of human fetal tissue except by certain authorized facilities to accredited universities, and prohibits the purchase or sale of human fetal tissue.

Tara Sander Lee,…
February 16, 2017
Fetal Tissue, Stem Cells & Bioethics

Video: Dr. Joel McGuirk and the Adult Stem Cell Revolution

Today the Charlotte Lozier Institute releases its sixth in its series of Stem Cell Research Facts videos. This story features the work of Dr. Joseph McGuirk, an adult stem cell expert at the University of Kansas Hospital, and tells the story of Chance Runnion’s recovery from leukemia after an adult stem cell transplant.

charlotte-lozier-institute Charlotte Lozier Institute
February 15, 2017
A person with curly hair and a friendly smile sits indoors, wearing a dark sweater. A calendar and shelving are visible in the background, offering a glimpse into everyday human life. The black-and-white photo evokes curiosity, like a scene from a science Q&A.
Fetal Tissue, Stem Cells & Bioethics

Q&A with the Scholars: Science and the Beginning of Human Life

Maureen Condic, Ph.D.
February 13, 2017
Transcript of Remarks of Chuck Donovan on the Release of “Abortion Worldwide Report”
Abortion

Transcript of Remarks of Chuck Donovan on the Release of “Abortion Worldwide Report”

On January 25, Charlotte Lozier Institute President Chuck Donovan presented opening remarks* at the Family Research Council during an event launching the major report entitled, “Abortion Worldwide Report: 100 Countries, 1 Century, 1 Billion Babies.”

Charles A. “Chuck”…
February 7, 2017
Maternal & Public Health

Q&A with the Scholars: Surrogacy and Assisted Reproductive Technology

Jennifer Lahl, R.N., M.A., is founder and president of The Center for Bioethics and Culture Network. Lahl couples her 25 years of experience as a pediatric critical care nurse, a hospital administrator, and a senior-level nursing manager with a deep passion to speak for those who have no voice. She serves on the North American Editorial Board for Ethics and Medicine and on the Board of Reference for the Institute on Disability. Ms. Lahl is one of our nearly 40 associate scholars. In this interview, she discusses surrogacy and assisted reproductive technology.

Jennifer Lahl, R.N.,…
February 6, 2017
End of Life

Lessons from the Netherlands: Proceed with Caution

The doctor asked the elderly Dutch woman’s family members to hold her down while the fatal dose was administered. The woman was suffering from dementia and had previously affirmed that she wanted to be euthanized “at the right time,” but the determination of the “right time” for her to die was apparently made without her consultation.

Tim Bradley
January 31, 2017

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image